TOMASSINI, VALENTINA
 Distribuzione geografica
Continente #
NA - Nord America 1.695
AS - Asia 916
EU - Europa 897
SA - Sud America 106
OC - Oceania 10
AF - Africa 7
Continente sconosciuto - Info sul continente non disponibili 2
Totale 3.633
Nazione #
US - Stati Uniti d'America 1.679
SG - Singapore 708
IE - Irlanda 271
IT - Italia 236
CN - Cina 99
BR - Brasile 94
RU - Federazione Russa 81
SE - Svezia 70
DE - Germania 64
GB - Regno Unito 58
VN - Vietnam 34
HK - Hong Kong 32
FI - Finlandia 22
UA - Ucraina 14
AT - Austria 13
FR - Francia 13
CA - Canada 11
TR - Turchia 10
AU - Australia 9
BE - Belgio 9
IN - India 8
CZ - Repubblica Ceca 7
NL - Olanda 7
RO - Romania 7
AR - Argentina 6
ES - Italia 6
BD - Bangladesh 5
IR - Iran 5
BG - Bulgaria 4
PK - Pakistan 4
CH - Svizzera 3
ZA - Sudafrica 3
EU - Europa 2
IQ - Iraq 2
JM - Giamaica 2
MD - Moldavia 2
PA - Panama 2
PL - Polonia 2
PT - Portogallo 2
TW - Taiwan 2
UZ - Uzbekistan 2
VE - Venezuela 2
AE - Emirati Arabi Uniti 1
CL - Cile 1
CO - Colombia 1
DK - Danimarca 1
DZ - Algeria 1
EC - Ecuador 1
EE - Estonia 1
HU - Ungheria 1
ID - Indonesia 1
JO - Giordania 1
JP - Giappone 1
KE - Kenya 1
MC - Monaco 1
ME - Montenegro 1
ML - Mali 1
MN - Mongolia 1
MX - Messico 1
NZ - Nuova Zelanda 1
PY - Paraguay 1
SK - Slovacchia (Repubblica Slovacca) 1
TN - Tunisia 1
Totale 3.633
Città #
Singapore 530
Chandler 286
Dublin 268
Santa Clara 148
Ashburn 109
The Dalles 100
Jacksonville 83
Princeton 82
Altamura 41
Los Angeles 38
Beijing 33
Dong Ket 33
Hong Kong 32
Wilmington 29
Nuremberg 23
Munich 20
Rome 20
Washington 20
Chieti 17
Seattle 16
Ann Arbor 15
Pescara 15
New York 14
Romola 14
Teramo 13
Falls Church 12
Helsinki 12
London 12
Milan 12
Boardman 11
Camerino 10
Moscow 10
Brussels 9
São Paulo 9
Brooklyn 8
Chicago 8
Fairfield 8
Lappeenranta 8
Southend 8
Castignano 7
Frankfurt am Main 7
Saint Petersburg 7
Woodbridge 7
Nanchang 6
Norwalk 6
Santander 6
Sydney 6
Cardiff 5
Düsseldorf 5
Istanbul 5
Oxford 5
Pune 5
Silvi 5
Tehran 5
Boston 4
Brno 4
Edinburgh 4
Houston 4
Izmir 4
Rio de Janeiro 4
Dallas 3
Hanover 3
Kensington 3
Lauterbourg 3
Menlo Park 3
Montreal 3
Naples 3
Ottawa 3
San Vito Chietino 3
Secaucus 3
Shanghai 3
Toronto 3
Vienna 3
Wuhan 3
Anápolis 2
Belo Horizonte 2
Bosio 2
Brasília 2
Cambridge 2
Cedar Lake 2
Chennai 2
Città Sant'Angelo 2
Curitiba 2
Dearborn 2
Elk Grove Village 2
Florence 2
Genoa 2
Goiânia 2
Guangzhou 2
Honolulu 2
Iasi 2
Jaú 2
Johannesburg 2
Juiz de Fora 2
Mansfield 2
Melbourne 2
Nova Iguaçu 2
Olomouc 2
Phoenix 2
Pianella 2
Totale 2.341
Nome #
Testosterone amplifies excitotoxic damage of cultured oligodendrocytes. 85
Comparing MRI metrics to quantify white matter microstructural damage in multiple sclerosis 84
Modelling the natural history of primary progressive multiple sclerosis 83
"Better explanations" in multiple sclerosis diagnostic workup: A 3-year longitudinal study 82
A flow-diffusion model of oxygen transport for quantitative mapping of cerebral metabolic rate of oxygen (CMRO2) with single gas calibrated fMRI 82
A multicentRE observational analysiS of PErsistenCe to Treatment in the new multiple sclerosis era: the RESPECT study 81
Neuroplasticity and motor rehabilitation in multiple sclerosis 79
Tractography in the presence of multiple sclerosis lesions 77
Relationship between Prolactin Plasma Levels and White Matter Volume in Women with Multiple Sclerosis 76
Clinical Outcomes of Escalation vs Early Intensive Disease-Modifying Therapy in Patients with Multiple Sclerosis 74
Oral contraceptives combined with interferon b in multiple sclerosis 73
Brain morphometry in Multiple Sclerosis 73
A cross-sectional, multicentre study of the therapeutic management of multiple sclerosis relapses in Italy 72
Contribution of metabolomics to multiple sclerosis diagnosis, prognosis and treatment 68
Assessment of the Effects of Aerobic Fitness on Cerebrovascular Function in Young Adults Using Multiple Inversion Time Arterial Spin Labeling MRI 66
Neurological update: MOG antibody disease 65
How common is truly benign MS in a UK population? 65
Dual-calibrated fMRI measurement of absolute cerebral metabolic rate of oxygen consumption and effective oxygen diffusivity 64
Predicting the profile of increasing disability in multiple sclerosis 63
Informing MS patients on treatment options: a consensus on the process of consent taking 60
Exergames for balance dysfunction in neurological disability: a meta-analysis with meta-regression 60
The effect of inflammation and its reduction on brain plasticity in multiple sclerosis: MRI evidence 59
Site-specific clinical disease onset in multiple sclerosis 59
Neurovascular Coupling During Visual Stimulation in Multiple Sclerosis: A MEG-fMRI Study 59
Characteristics and treatment of Multiple Sclerosis-related trigeminal neuralgia: An Italian multi-centre study 58
Cerebral Metabolic Changes During Visuomotor Adaptation Assessed Using Quantitative fMRI 56
Impact of the 2017 revisions to McDonald criteria on the diagnosis of multiple sclerosis 55
A frequency-domain machine learning method for dual-calibrated fMRI mapping of oxygen extraction fraction (OEF) and cerebral metabolic rate of oxygen consumption (CMRO 2) 54
Effect on Cognition of Estroprogestins Combined with Interferon Beta in Multiple Sclerosis: Analysis of Secondary Outcomes from a Randomised Controlled Trial 54
Cerebrovascular reactivity in multiple sclerosis is restored with reduced inflammation during immunomodulation 53
Pathophysiology of multiple sclerosis damage and repair: Linking cerebral hypoperfusion to the development of irreversible tissue loss in multiple sclerosis using magnetic resonance imaging 49
Impaired Functional Connectivity Unmasked by Simple Repetitive Motor Task in Early Relapsing-Remitting Multiple Sclerosis 49
Medical education and MS: getting the training right 48
Case Report: Multiple Sclerosis Relapses After Vaccination Against SARS-CoV2: A Series of Clinical Cases 48
Defining the course of tumefactive multiple sclerosis: A large retrospective multicentre study 45
mRNA COVID-19 vaccines do not increase the short-term risk of clinical relapses in multiple sclerosis 45
Diagnosis and management of multiple sclerosis: MRI in clinical practice 43
A multicenter survey on access to care in Multiple Sclerosis-related trigeminal neuralgia 43
Harmonization of real-world studies in multiple sclerosis: Retrospective analysis from the rirems group 41
Serum MMP-9/TIMP-1 and MMP-2/TIMP-2 ratios in multiple sclerosis: relationships with different magnetic resonance imaging measures of disease activity during IFN-beta-1a treatment 40
Anti-myelin antibodies predict the clinical outcome after a first episode suggestive of MS 40
Corrigendum: A Frequency-Domain Machine Learning Method for Dual-Calibrated fMRI Mapping of Oxygen Extraction Fraction (OEF) and Cerebral Metabolic Rate of Oxygen Consumption (CMRO 2) 39
Management of hepatitis B virus prophylaxis in patients treated with disease-modifying therapies for multiple sclerosis: a multicentric Italian retrospective study 38
The effect of hypointense white matter lesions on automated gray matter segmentation in multiple sclerosis 37
Age-related changes in grey and white matter structure throughout adulthood 36
Breath-hold BOLD fMRI without CO2 sampling enables estimation of venous cerebral blood volume: potential use in normalization of stimulus-evoked BOLD fMRI data 36
Similarities and differences between multiple sclerosis and type 1 diabetes 36
Predictors of training-related improvement in visuomotor performance in patients with multiple sclerosis: A behavioural and MRI study 35
Neutralizing and binding antibodies to IFN-beta: relative frequency in relapsing-remitting multiple sclerosis patients treated with different IFN-beta preparations 34
The effect of disease activity on leptin, leptin receptor and suppressor of cytokine signalling-3 expression in relapsing-remitting multiple sclerosis 34
A 6-year clinical and MRI follow-up study of patients with relapsing-remitting multiple sclerosis treated with Interferon-beta 33
Neuroplasticity and functional recovery in multiple sclerosis 33
Guillain−Barré syndrome and SARS-CoV-2 infection: a systematic review and meta-analysis on a debated issue and evidence for the ‘Italian factor’ 33
Lessons from immunotherapies in multiple sclerosis 33
Mechanisms of Network Changes in Cognitive Impairment in Multiple Sclerosis 33
Preservation of motor skill learning in patients with multiple sclerosis 32
Pronounced focal and diffuse brain damage predicts short-term disease evolution in patients with clinically isolated syndrome suggestive of multiple sclerosis 32
Contemporary study of multiple sclerosis disability in South East Wales 32
Correction to: Management of hepatitis B virus prophylaxis in patients treated with disease-modifying therapies for multiple sclerosis: a multicentric Italian retrospective study 31
Relating brain damage to brain plasticity in patients with multiple sclerosis 30
SARS-CoV-2 vaccination and multiple sclerosis: a large multicentric study on relapse risk after the third booster dose 29
Guillain–Barré syndrome and COVID-19 vaccination: a systematic review and meta-analysis 29
Thyroid autoimmunity and dysfunction in multiple sclerosis patients during long-term treatment with interferon beta or glatiramer acetate: an Italian multicenter study 28
Brain atrophy in relapsing-remitting multiple sclerosis: relationship with 'black holes', disease duration and clinical disability 28
Model-free characterization of brain functional networks for motor sequence learning using fMRI 28
Relationship between emotional distress in caregivers and health status in persons with multiple sclerosis 27
Comparison of the effects of acetyl L-carnitine and amantadine for the treatment of fatigue in multiple sclerosis: results of a pilot, randomised, double-blind, crossover trial 27
Psychopathological and cognitive effects of therapeutic cannabinoids in multiple sclerosis: a double-blind, placebo controlled, crossover study 27
Evidence of impaired brain activity balance after passive sensorimotor stimulation in multiple sclerosis 27
Structural and functional bases for individual differences in motor learning 26
Reduced brain oxygen metabolism in patients with multiple sclerosis: Evidence from dual-calibrated functional MRI 26
Predictors of long-term clinical response to interferon beta therapy in relapsing multiple sclerosis 25
Diffusion-Weighted Imaging Tractography-Based Parcellation of the Human Parietal Cortex and Comparison with Human and Macaque Resting-State Functional Connectivity 25
Changes of brain parenchyma free water fraction reflect tissue damage and impaired processing speed in multiple sclerosis 24
Post-marketing survey on clinical response to interferon beta in relapsing multiple sclerosis: the Roman experience 24
Cannabinoid-induced effects on the nociceptive system: a neurophysiological study in patients with secondary progressive multiple sclerosis 24
Changes in brain perfusion with training-related visuomotor improvement in MS 24
Diffusion-weighted imaging tractography-based parcellation of the human lateral premotor cortex identifies dorsal and ventral subregions with anatomical and functional specializations 24
A tractometry principal component analysis of white matter tract network structure and relationships with cognitive function in relapsing-remitting multiple sclerosis 22
Progressive multifocal leukoencephalopathy or severe multiple sclerosis relapse following COVID-19 vaccine: a diagnostic challenge 22
Real world experience with teriflunomide in multiple sclerosis: the TER-Italy study 22
Routine CSF parameters as predictors of disease course in multiple sclerosis: an MSBase cohort study 21
Multiple sclerosis lesions: insights from imaging techniques 21
Motor practice promotes increased activity in brain regions structurally disconnected after subcortical stroke 20
Neutralizing antibodies explain the poor clinical response to interferon beta in a small proportion of patients with multiple sclerosis: a retrospective study 20
Sex hormones, brain damage and clinical course of Multiple Sclerosis 19
Distinct and overlapping functional zones in the cerebellum defined by resting state functional connectivity 19
Endogenous retroviruses in multiple sclerosis: A network-based etiopathogenic model 19
Interferon beta treatment of MS in the daily clinical setting: a 3-year post-marketing study 18
Sex hormones: a role in the control of multiple sclerosis? 17
Alexithymia in multiple sclerosis: relationship with fatigue and depression 17
Fate of neutralizing and binding antibodies to IFN beta in MS patients treated with IFN beta for 6 years 17
Sex hormones modulate brain damage in multiple sclerosis: MRI evidence 16
Monthly corticosteroids decrease neutralizing antibodies to IFNbeta1 b: a randomized trial in multiple sclerosis 15
"Back to Braak": Role of Nucleus Reuniens and Subcortical Pathways in Alzheimer's Disease Progression 14
'Gender gap' in multiple sclerosis: magnetic resonance imaging evidence 14
Transverse myelitis in children and adults 11
Targeting ASIC1 in primary progressive multiple sclerosis: evidence of neuroprotection with amiloride 11
Investigating social cognition in Multiple Sclerosis: Does Implicit Biological Motion processing affect visuo-spatial attention? 7
null 1
Totale 4.012
Categoria #
all - tutte 23.821
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.821


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202070 0 0 0 0 0 0 0 0 0 0 57 13
2020/2021185 21 18 35 7 2 29 8 14 6 5 0 40
2021/2022209 1 1 3 3 8 12 3 37 25 5 17 94
2022/2023889 76 131 41 85 70 143 57 62 100 42 46 36
2023/2024640 52 21 55 24 32 184 116 41 15 33 14 53
2024/20251.836 120 544 421 52 47 58 76 82 192 147 97 0
Totale 4.012